期刊文献+

重症监护病房感染患者病原菌分布及耐药分析 被引量:4

Analysis of the distribution and drug resistance of pathogenic bacteria in intensive care unit
下载PDF
导出
摘要 目的了解重症监护病房病原菌分布特点及耐药情况。方法采用安徽恒星HX-21细菌鉴定药敏分析仪对我院2008年3月~2009年12月送检标本中分离的病原菌进行鉴定及耐药分析。结果 394株病原菌中以革兰阴性杆菌为主,主要有鲍曼不动杆菌、铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌。多重耐药菌较常见。对亚胺培南、头孢哌酮/舒巴坦、哌拉西林/他唑巴坦敏感性较高。结论了解病原菌耐药情况,指导临床合理用药。 Objective To understand the distribution and drug resistance of pathogenic bacteria in intensive care unit.Methods Pathogenic bacteria isolated from samples of our hospital which were from March 2008 to December 2009 were identified and drug resistance was analyzed by using Anhui-Hengxing-HX-21 bacteria appraisal susceptibility.Results 136 strains of pathogenic bacteria to gramnegative,mainly acinetobacter baumannii,pseudomonas aeruginosa,escherichia coli,pneumonia crayresearch bacteria.Multiple drug-resistant bacteria were common.It had a higher sensitivity to imipenem,cefoperazone sodium and sulbactam sodium and piperacillin-tazobactam.Conclusion Understanding of pathogen drug resistance guides clinical rational use of drug.
出处 《临床肺科杂志》 2010年第8期1109-1110,共2页 Journal of Clinical Pulmonary Medicine
关键词 重症监护病房 病原菌 耐药性 intensive care unit pathogenic bacteria drug resistance
  • 相关文献

参考文献3

二级参考文献9

  • 1Valero C, Garcia Palomo JD, Matorras P, et al. Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Inter Medicine,2001,12:425-429.
  • 2Corona-Nakamura AL, Miranda-Novales MG, Leanos-Miranda B, et al. Epidemiologyic study of Pseudomonas aeruginosa in critical patients and reservoirs. Archives Medical Res,2001,32:238-242.
  • 3Cormican MG,Marshall SA, Jones RN. Detection of extended-spectrum β-lactames (ESBL)-producing strains by the E-test ESBL screen. J Clin Microbiol,1996,34:880-885.
  • 4National committee for clinical Laboratory standards. 2002. Performance Standards for antimicrobial Susceptibility testing Document M100-S10(M7). National committee for clinical Laboratory standards,Wayne,Pa.2002,1.42-49.
  • 5Hirakata Y, Izumikawa K, Yamaguchi T, et al. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother, 1998,42:2006-2011.
  • 6Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-Hydrolyzing Metallo-β-lactamase and its plasmid-and integron-borne gene from a pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 2000,44:891-897.
  • 7Dentton M,Kerr KG.Microbiological and clinical aspects of infection associated with Stenotropomonas maltophilia.Clin Microbiol Rev, 1998;11:57-80.
  • 8Woodford N, Johnson AP. Molecular Bacteriology Protocols and Clinical Applications. Published by HUMANA PRESS, 558-560.
  • 9Vila J, Ruiz J, Navia M, et al.. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol,1999,37:758-761.

共引文献176

同被引文献21

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部